While CAMs regulate migration, the major PC5diagnosis marker, S100B, is an astrocyte-expressed protein indicating BBB disruption (Futtrup et al., 2020) due to e.g. brain trauma and cerebrovascular diseases (Chong et al., 2016). This evidence concerns the gene S100B and cerebrovascular disorder.